PMID: 8471919Mar 13, 1993Paper

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability

BMJ : British Medical Journal
F SongJ Mason

Abstract

To examine the evidence for using selective serotonin reuptake inhibitors instead of tricyclic antidepressants in the first line treatment of depression. Meta-analysis of 63 randomised controlled trials comparing the efficacy and acceptability of selective serotonin reuptake inhibitors with those of tricyclic and related antidepressants. Improvement in mean scores on Hamilton depression rating scale for 53 randomised controlled trials. Pooled drop out rates from the 58 trials which reported drop out by treatment group. Among the 20 studies reporting standard deviation for the Hamilton score no difference was found in efficacy between serotonin reuptake inhibitors and tricyclic and related antidepressants (standardised mean difference 0.004, 95% confidence interval -0.096 to 0.105). The difference remained insignificant when the remaining 33 studies that used the 17 item and 21 item Hamilton score were included by ascribing weighted standard deviations. The odds ratio for drop out rate in patients receiving serotonin reuptake inhibitors compared with those receiving tricyclic antidepressants was 0.95 (0.86 to 1.07). Similar proportions in both groups cited lack of efficacy as the reason for dropping out but slightly more patient...Continue Reading

References

Oct 31, 1992·Lancet·A LeizoroviczJ P Boissel
Nov 14, 1992·BMJ : British Medical Journal·E S Paykel, R G Priest
Jun 27, 1992·BMJ : British Medical Journal·J G Edwards
Aug 1, 1991·British Journal of Clinical Pharmacology·S ShawketM J Brown
Jan 1, 1991·International Clinical Psychopharmacology·D KeeganA Boulton
Jan 1, 1990·Current Medical Research and Opinion·G GonellaU Ecari
Jan 1, 1990·Progress in Neuro-psychopharmacology & Biological Psychiatry·D RothD V Sheehan
Jan 1, 1990·Current Medical Research and Opinion·A Perez, J J Ashford
Jul 1, 1989·International Clinical Psychopharmacology·J P FeighnerG G Hendrickson
Jan 1, 1989·Acta Psychiatrica Scandinavica. Supplementum·E GuillibertY Thobie
Jan 1, 1989·Acta Psychiatrica Scandinavica. Supplementum·H Kuhs, G A Rudolf
Apr 1, 1989·International Clinical Psychopharmacology·J P FeighnerG G Hendrickson
Jul 1, 1989·International Clinical Psychopharmacology·S J Corne, J R Hall
Oct 1, 1989·Journal of Geriatric Psychiatry and Neurology·W E FalkR A Nixon
Feb 1, 1989·Statistics in Medicine·J A BerlinT C Chalmers
Feb 1, 1989·Journal of Clinical Psychopharmacology·K BradyR B Lydiard
Sep 1, 1988·Acta Psychiatrica Scandinavica·M MuijenM Christie
Mar 1, 1985·Acta Psychiatrica Scandinavica·A L LaursenP le Fèvre Honoré
Apr 1, 1988·Journal of Clinical Psychopharmacology·W F ByerleyB I Grosser
May 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·S LevineK Mahadevan
Sep 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·J P YoungM H Lader
Apr 1, 1987·Statistics in Medicine·R Peto
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Dec 1, 1967·The British Journal of Social and Clinical Psychology·M Hamilton
Dec 1, 1984·Journal of Affective Disorders·K R NortonE S Paykel
Jan 1, 1983·British Journal of Clinical Pharmacology·J D GuelfiP Pichot
Jan 1, 1983·British Journal of Clinical Pharmacology·T M ItilS T Michael
Feb 8, 1992·Quality in Health Care : QHC·A F Long, T A Sheldon
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON

❮ Previous
Next ❯

Citations

Apr 23, 2002·The Journal of Mental Health Policy and Economics·Deborah G. DobrezRobert L. Obenchain
Aug 9, 2007·Cancer Causes & Control : CCC·Sengwee TohSonia Hernández-Díaz
Nov 30, 2000·Current Treatment Options in Neurology·C D Schneck, R D Buzan
Dec 9, 1994·Health Policy·A Maynard, A Walker
Feb 20, 2004·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·G BassottiA Morelli
Apr 18, 1998·Journal of Affective Disorders·N MittmannN H Shear
Jul 21, 1998·Journal of Affective Disorders·A Stewart
Jan 29, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Meera VaswaniSubramanyam Ramesh
Nov 16, 2002·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Steve HermanP Murali Doraiswamy
Aug 12, 1999·The Australian and New Zealand Journal of Psychiatry·P Boyce, F Judd
Aug 28, 1997·The New England Journal of Medicine·F P RivaraP Cummings
Jun 1, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·H L LeonardA J Allen
Dec 20, 2007·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Mugdha ThakurDavid B Matchar
Sep 25, 1993·BMJ : British Medical Journal·T Hale
Jul 23, 1994·BMJ : British Medical Journal·N FreemantleT A Sheldon
Nov 12, 1994·BMJ : British Medical Journal·D Owens
Jan 14, 1995·BMJ : British Medical Journal·M McKee, A Clarke
Dec 16, 1995·BMJ : British Medical Journal·A J Cleare
Aug 31, 1996·BMJ : British Medical Journal·J Anderson, C Adams
Oct 5, 1996·BMJ : British Medical Journal·T Kendrick
Jun 18, 1999·BMJ : British Medical Journal·M G Livingston, H M Livingston
Jul 1, 1996·Postgraduate Medical Journal·C Trescoli-Serrano, N K Smith
Feb 7, 1995·Quality in Health Care : QHC·T A SheldonF Song
Dec 16, 2005·The AAPS Journal·Kellie J WhiteEric L Barker
Sep 8, 2000·PharmacoEconomics·M T Jones, P C Cockrum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.